Imago BioSciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Imago BioSciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2022.
  • Imago BioSciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$16.8M, a 43.8% decline year-over-year.
  • Imago BioSciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$61.6M, a 86% decline year-over-year.
  • Imago BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$42.3M, a 137% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$61.6M -$16.8M -$5.11M -43.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$56.5M -$13.7M -$4.94M -56% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-09
Q1 2022 -$51.6M -$16.4M -$9.29M -131% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-09
Q4 2021 -$42.3M -$14.7M -$9.18M -165% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-24
Q3 2021 -$33.1M -$11.7M -$7.36M -171% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$25.8M -$8.81M -$5.08M -136% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$20.7M -$7.11M -$2.86M -67.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$17.8M -$5.55M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$4.31M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.73M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$4.25M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.